3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Classical hematology
1
CNS
1
Conditions
Myelodysplastic Syndromes
21
Leukemia
20
Leukemia, Myeloid, Chronic-Phase
17
Precursor Cell Lymphoblastic Leukemia-Lymphoma
15
Anemia, Refractory, with Excess of Blasts
15
Leukemia, Myeloid, Accelerated Phase
14
Lymphoma
13
Leukemia, Myeloid, Acute
11
Burkitt Lymphoma
11
Myeloproliferative Disorders
10
Leukemia, Myelomonocytic, Chronic
10
Anemia, Refractory
10
Myelodysplastic-Myeloproliferative Diseases
9
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
9
Leukemia, Lymphocytic, Chronic, B-Cell
9
Dendritic Cell Sarcoma, Interdigitating
9
Blast Crisis
9
Recurrence
8
Neoplasms, Plasma Cell
8
Multiple Myeloma
8
Lymphoma, Follicular
8
Lymphoma, B-Cell, Marginal Zone
8
Congenital Abnormalities
8
Lymphoma, Non-Hodgkin
7
Lymphoma, Mantle-Cell
7
Lymphoma, Large-Cell, Immunoblastic
7
Lymphoma, Large B-Cell, Diffuse
7
Graft vs Host Disease
7
Primary Myelofibrosis
6
Hodgkin Disease
6
Interventions
ziprasidone
1
Zolpidem
1
Warfarin
1
Vecuronium Bromide
1
Vancomycin
1
Tranexamic Acid
1
Tobramycin
1
Spironolactone
1
Sevelamer
1
Rocuronium
1
Piperacillin, Tazobactam Drug Combination
1
Pentobarbital
1
Oxycodone
1
Nifedipine
1
Nafcillin
1
Molindone
1
Methylprednisolone
1
Lurasidone Hydrochloride
1
Labetalol
1
Haloperidol
1
Fosfomycin
1
Clozapine
1
Ciprofloxacin
1
Cidofovir
1
Cefepime
1
Bosentan
1
Aminocaproic Acid
1
Amikacin
1
Alfentanil
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Meningitis, Bacterial
×
Methylprednisolone
×
Classical hematology
×
Clear all
NCT01431326
2023-09-06
PTN_POPS
Duke University
Completed
3,520 enrolled